8
Clinical Trials associated with Varicella vaccine(Changchun Keygen Biological Products Co. Ltd.) / Active, not recruitingPhase 3 水痘减毒活疫苗13岁及以上人群随机、盲法、同类疫苗对照的免疫原性和安全性Ⅲ期临床试验
[Translation] A randomized, blinded, similar vaccine-controlled phase III clinical trial on the immunogenicity and safety of varicella live attenuated vaccine in people aged 13 years and above
评价水痘减毒活疫苗在13岁及以上人群中接种二剂疫苗的安全性和免疫原性
[Translation] To evaluate the safety and immunogenicity of two doses of live attenuated varicella vaccine in people aged 13 years and older
Phase III clinical trial of randomized, blinded, controlled immunogenicity and safety of live attenuated varicella vaccine in people aged 13 years and older
Start Date05 Jun 2023 |
Sponsor / Collaborator- |
随机、盲法、同类疫苗对照试验评价水痘减毒活疫苗2剂免疫程序免疫原性和安全性的Ⅲ期临床试验
[Translation] A phase III randomized, blinded, similar vaccine-controlled trial to evaluate the immunogenicity and safety of a two-dose immunization schedule of live attenuated varicella vaccine
主要目的:评价水痘减毒活疫苗在13岁及以上人群中接种二剂疫苗的免疫原性(抗体阳转率和抗体水平);次要目的:评价水痘减毒活疫苗在13岁及以上人群中接种二剂疫苗的安全性。
[Translation] The primary objective is to evaluate the immunogenicity (antibody seroconversion rate and antibody level) of two doses of varicella live attenuated vaccine in people aged 13 years and above. The secondary objective is to evaluate the safety of two doses of varicella live attenuated vaccine in people aged 13 years and above.
100 Clinical Results associated with Varicella vaccine(Changchun Keygen Biological Products Co. Ltd.)
100 Translational Medicine associated with Varicella vaccine(Changchun Keygen Biological Products Co. Ltd.)
100 Patents (Medical) associated with Varicella vaccine(Changchun Keygen Biological Products Co. Ltd.)
100 Deals associated with Varicella vaccine(Changchun Keygen Biological Products Co. Ltd.)